Pandemics
  • Videos
  • March 2022
  • 9:53 minutes

A Balancing Act: Vaccination Status and Insurance Pricing

In Brief

Curious about RGA's medical insights?  Contact us to learn more. 

This video was developed in conjunction with actuview, the first permanent international media platform for actuaries (www.actuview.com). actuview content reflects contributions from actuarial institutions, corporate partners and industry professionals. RGA is actuview’s sponsoring partner.

During the second and third waves in South Africa, for example, mortality rates for fully underwritten retail policies peaked at more than four times the expected level. However, using vaccination status is a complex challenge to solve and ultimately requires insurers to balance many different considerations. Neil Parkin, Head of Business development, RGA South Africa, explores the pros and cons of adding vaccination status as a rating factor.

See also:  Vaccination Status: Insurance Pricing Considerations


At RGA, we are eager to engage with clients to better understand and tackle the industry’s most pressing challenges together. Contact us to discuss and learn more about the RGA capabilities, resources, and solutions.  




More Like This...

  • The Old, the New, and the Borrowed: SARS-CoV-2 Vaccines and Beyond
    Read More
  • Vaccination Status: Insurance Pricing Considerations
    Read More
  • mRNA Vaccines: Is the future now?
    Read More
  • Duration of Natural and Vaccine-induced COVID-19 Immunity: What we know and what we need to learn
    Read More
  • COVID-19 and Mental Health Claims: A Guide for Claims Case Managers
    Read More
  • View All RGA Articles

Meet the Authors & Experts

Expert
Neil Parkin
Head of Business Development, RGA South Africa